Hyperprolactinemia as a manifestation of multiple sclerosis attack

Area of Science:

• Neurology
• Endocrinology

Background:

• Multiple Sclerosis (MS) is a chronic inflammatory neurological disease.
• Hyperprolactinemia, characterized by elevated prolactin levels, affects 6.7% of MS patients.
• Galactorrhea is a rare presenting symptom in patients with Multiple Sclerosis.

Purpose of the Study:

• To report a case of Multiple Sclerosis presenting with hyperprolactinemia and galactorrhea.
• To investigate the potential association between MS and hyperprolactinemia.
• To evaluate the treatment response of hyperprolactinemia in the context of MS management.

Main Methods:

• Case report methodology.
• Clinical observation of a 31-year-old female patient with MS.
• Monitoring of serum prolactin levels and pituitary gland imaging.

Main Results:

• The patient exhibited galactorrhea and elevated serum prolactin levels, with a normal pituitary gland.
• Intravenous methylprednisolone treatment for MS led to the normalization of prolactin levels.
• Galactorrhea resolved following methylprednisolone administration, without the use of dopaminergic agents.

Conclusions:

• This case suggests a potential link between Multiple Sclerosis and hyperprolactinemia.
• When hyperprolactinemia is associated with MS, treatment targeting MS may suffice.
• Specific treatment for hyperprolactinemia may not be necessary if MS is the underlying cause.